Rapid responses are electronic comments to the editor. They enable our users to debate issues raised in articles published on bmj.com. A rapid response is first posted online. If you need the URL (web address) of an individual response, simply click on the response headline and copy the URL from the browser window. A proportion of responses will, after editing, be published online and in the print journal as letters, which are indexed in PubMed. Rapid responses are not indexed in PubMed and they are not journal articles. The BMJ reserves the right to remove responses which are being wilfully misrepresented as published articles.
We would like to thank Deborah Cohen for her report on the agreement
reached between Medtronic and Yale University to release all unpublished
trial data relating to products containing recombinant human bone
morphogenetic protein-2. However, there is a slight error in the
statement that "He (Dr Krumholz) will head a steering committee that will
commission two separate organisations with expertise in conducting large
systematic reviews to evaluate the data on rhBMP-2."
In fact, the Steering Committee which is advisory to this process will be
chaired by Dr Ezekiel Emanuel, and the committee members will be chosen
with his guidance to include many different perspectives and to provide a
wide range of relevant experience and expertise.
No competing interests
06 September 2011
Harlan M Krumholz
Harold H. Hines Jr. Professor of Medicine (Cardiology) and Professor of Investigative Medicine and o